VAERS reports by lot

GSK Varicella/Shingles lot C7B9P: VAERS reports

57 VAERS reports list lot C7B9P as a GSK Varicella/Shingles vaccine, received between 2018-08-13 and 2019-10-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
57
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6227%
Injection-site / Local reaction4419%
Dermatological (non-injection-site)3214%
Neurological2913%
Gastrointestinal188%
Allergic / Anaphylactic167%
Musculoskeletal146%
Cardiac / Cardiovascular115%
Respiratory31%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina5
Pennsylvania5
Michigan4
Wisconsin4
California3
Montana3
Texas3
New York3
Florida3
Indiana2
New Jersey2
West Virginia2

Reports by month received

2018-0817
2018-0912
2018-108
2018-1110
2018-121
2019-012
2019-021
2019-031
2019-041
2019-052
2019-081
2019-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.